Enlivex Therapeutics Ltd. raised $212 million through a private equity deal and is using much of it to build a digital asset treasury with the RAIN token, a decentralized prediction market protocol. The company holds 76 billion RAIN tokens with potential for more, while also making progress in clinical trials for its osteoarthritis therapy Allocetra. Analysts see potential for significant value growth.

Leave a Reply